AETERNA LAB INC has a total of 72 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are LAB AETERNA INC, AETERNA ZENTARIS INC and ASAC COMPANIA DE BIOTECNOLOGIA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 8 | |
#3 | Canada | 7 | |
#4 | EPO (European Patent Office) | 6 | |
#5 | Australia | 5 | |
#6 | Brazil | 4 | |
#7 | China | 4 | |
#8 | New Zealand | 4 | |
#9 | Bulgaria | 3 | |
#10 | Czechia | 3 | |
#11 | Mexico | 3 | |
#12 | Poland | 3 | |
#13 | Romania | 3 | |
#14 | Hong Kong | 2 | |
#15 | Hungary | 2 | |
#16 | South Africa | 2 | |
#17 | Argentina | 1 | |
#18 | Israel | 1 | |
#19 | India | 1 | |
#20 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Unspecified technologies | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Dupont Eric | 65 |
#2 | Brazeau Paul | 42 |
#3 | Juneau Christina | 39 |
#4 | Marenus Kenneth | 31 |
#5 | Maes Daniel H | 29 |
#6 | Auger Serge | 12 |
#7 | Lessard Denis | 12 |
#8 | Lachance Yves | 11 |
#9 | Beliveau Richard | 6 |
#10 | Meas Daniel H | 3 |
Publication | Filing date | Title |
---|---|---|
AU2002325108A1 | Serine protease inhibitor and processes for the preparation thereof | |
WO02100421A1 | Low molecular weight components of cartilage, complexes of copper with amino acids or di-peptides; processes for preparation and therapeutic uses thereof | |
AU1553602A | Compositions | |
CA2299956A1 | Shark cartilage extract: process of making, methods of using and compositions thereof | |
US6380366B1 | Shark cartilage extract:process of making, methods of using and compositions thereof | |
US6168807B1 | Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof | |
EP0967987A1 | Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents | |
US6028118A | Methods of using extracts of shark cartilage | |
AU6653796A | Extracts of shark cartilage | |
US6025334A | Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof | |
NZ294553A | Extracts obtained from centrifuging an aqueous homogenate of whole shark cartilage; production and use |